Reaction

Ovarian Cancer Stage Iv reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 416 reports · 3 co-occurring drugs

As of the last recalculation, Ovarian Cancer Stage Iv appears in 416 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is NIRAPARIB (PRR 32.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Niraparib	14	32.6	32.6
Olaparib	10	24.5	24.5
Rucaparib	4	22.9	22.9

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.